Sensible approaches for reducing clinical trial costs.
BACKGROUND: Over the past decade, annual funding for biomedical research has more than doubled while new molecular entity approvals have declined by one third. OBJECTIVE: To assess the value of practices commonly employed in the conduct of large-scale clinical trials, and to identify areas where cos...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
2008
|